Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients.

HO-1 bone marrow transplantation single nucleotide polymorphism unrelated donor

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
12 Feb 2020
Historique:
received: 10 01 2020
revised: 31 01 2020
accepted: 10 02 2020
entrez: 16 2 2020
pubmed: 16 2 2020
medline: 16 2 2020
Statut: epublish

Résumé

Heme oxygenase-1 (HO-1), an intracellular enzyme that catalyzes the degradation of heme into biliverdin, free iron, and carbon monoxide, exerts anti-inflammatory and cytoprotective effects against endothelial cell injury. The

Identifiants

DOI: 10.3390/cancers12020424 PMID: 32059452 PMC: PMC7072481
pubmed: 32059452
pii: cancers12020424
doi: 10.3390/cancers12020424
pmc: PMC7072481
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Health, Labour and Welfare
ID : H23-010
Organisme : Ministry of Education, Culture, Sports and Technology
ID : 18K08343

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

FASEB J. 1988 Jul;2(10):2557-68
pubmed: 3290025
Antioxid Redox Signal. 2014 Apr 10;20(11):1789-809
pubmed: 24131232
Transpl Immunol. 2016 Jul;37:10-17
pubmed: 27168057
Blood. 2007 Oct 1;110(7):2235-41
pubmed: 17554059
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Int J Hematol. 2016 Jan;103(1):11-9
pubmed: 26588927
Int J Hematol. 2016 Jan;103(1):3-10
pubmed: 26547570
Science. 1987 Feb 27;235(4792):1043-6
pubmed: 3029864
Biol Blood Marrow Transplant. 2014 Oct;20(10):1493-500
pubmed: 24813168
Biol Blood Marrow Transplant. 2004 Jul;10(7):484-93
pubmed: 15205669
Antioxidants (Basel). 2017 May 05;6(2):
pubmed: 28475131
Oncotarget. 2017 Jul 11;8(28):45670-45686
pubmed: 28484092
N Engl J Med. 1998 Oct 22;339(17):1177-85
pubmed: 9780337
Chin Med J (Engl). 2014;127(15):2795-801
pubmed: 25146616
Atherosclerosis. 2004 Apr;173(2):315-9
pubmed: 15064108
PLoS One. 2016 Dec 20;11(12):e0168210
pubmed: 27997582
Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56
pubmed: 16338616
Biol Blood Marrow Transplant. 2004 Jul;10(7):461-72
pubmed: 15205667
J Biol Chem. 2011 May 6;286(18):16374-85
pubmed: 21454555
J Clin Invest. 1999 Jan;103(1):129-35
pubmed: 9884342
Eur J Med Chem. 2017 Dec 15;142:163-178
pubmed: 28756878
Nat Med. 2000 Apr;6(4):422-8
pubmed: 10742149
Bone Marrow Transplant. 2011 Dec;46(12):1495-502
pubmed: 21460864
Biol Blood Marrow Transplant. 2007 Mar;13(3):315-28
pubmed: 17317585
Stat Med. 1999 Mar 30;18(6):695-706
pubmed: 10204198
J Exp Med. 2000 Oct 2;192(7):1015-26
pubmed: 11015442
Blood Adv. 2019 Aug 13;3(15):2424-2435
pubmed: 31409584
Am J Med. 1980 Aug;69(2):204-17
pubmed: 6996481
Br J Haematol. 1997 Jun;97(4):855-64
pubmed: 9217189
Thromb Res. 2012 Sep;130(3):e188-93
pubmed: 22819264
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076
Biol Blood Marrow Transplant. 2016 Sep;22(9):1573-1581
pubmed: 27246373
Br J Haematol. 2017 Jul;178(1):106-111
pubmed: 28439877
Transpl Immunol. 2017 Jun;42:34-39
pubmed: 28487238
Antioxidants (Basel). 2019 Sep 16;8(9):
pubmed: 31527528
Pediatr Res. 2015 Jun;77(6):793-8
pubmed: 25751573
Biol Blood Marrow Transplant. 2019 Nov;25(11):2251-2260
pubmed: 31271887
Int J Mol Sci. 2019 Jan 08;20(1):
pubmed: 30626079
Transpl Immunol. 2016 Sep;38:60-6
pubmed: 27369862
Cancers (Basel). 2019 Dec 25;12(1):
pubmed: 31881776
Haematologica. 2009 Oct;94(10):1427-34
pubmed: 19794085
Blood. 2014 Aug 28;124(9):1522-30
pubmed: 24963040
Int J Hematol. 2013 Sep;98(3):309-18
pubmed: 23949916
Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):23-32
pubmed: 18162218
Int J Hematol. 2015 Oct;102(4):460-70
pubmed: 26246110
Transplantation. 2007 Oct 15;84(7):917-25
pubmed: 17984846
Bone Marrow Transplant. 2016 Mar;51(3):403-9
pubmed: 26595082
Bone Marrow Transplant. 2007 Aug;40(4):381-7
pubmed: 17563735
Ann Surg. 2009 May;249(5):806-13
pubmed: 19387321
Biol Blood Marrow Transplant. 2019 Aug;25(8):1486-1491
pubmed: 30871975
Am J Transplant. 2008 Feb;8(2):377-85
pubmed: 18093274
Biol Blood Marrow Transplant. 2009 Mar;15(3):367-9
pubmed: 19203728
Nat Med. 1996 Jan;2(1):87-90
pubmed: 8564848
N Engl J Med. 1993 Mar 4;328(9):593-602
pubmed: 8429851
Sci Rep. 2016 Jun 13;6:27915
pubmed: 27295076
Lancet. 2002 Jun 15;359(9323):2078-83
pubmed: 12086762

Auteurs

Tomohiro Horio (T)

Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Nagakute 480-1195, Japan.

Eriko Morishita (E)

Department of Clinical Laboratory Science, Kanazawa University School of Medical Sciences, Kanazawa 920-0942, Japan.

Shohei Mizuno (S)

Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Nagakute 480-1195, Japan.

Kaori Uchino (K)

Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Nagakute 480-1195, Japan.

Ichiro Hanamura (I)

Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Nagakute 480-1195, Japan.

J Luis Espinoza (JL)

Department of Clinical Laboratory Science, Kanazawa University School of Medical Sciences, Kanazawa 920-0942, Japan.

Yasuo Morishima (Y)

Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Central Japan Cord Blood Bank, Seto 489-8555, Japan.
Department of Hematology and Oncology, Nakagami Hospital, Okinawa 904-2195, Japan.

Yoshihisa Kodera (Y)

Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Nagakute 480-1195, Japan.
Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.

Makoto Onizuka (M)

Department of Hematology and Oncology, Tokai University School of Medicine, Isehara 259-1193, Japan.

Koichi Kashiwase (K)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo 135-8521, Japan.

Takahiro Fukuda (T)

Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital, Tokyo 104-0045, Japan.

Noriko Doki (N)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo 113-8677, Japan.

Koichi Miyamura (K)

Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya 453-8511, Japan.

Takehiko Mori (T)

Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.

Shinji Nakao (S)

Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-8641, Japan.

Akiyoshi Takami (A)

Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Nagakute 480-1195, Japan.

Classifications MeSH